VenoStent

company

About

VenoStent is biomaterials company developing bioresorbable, smart polymers to transform vascular surgery.

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.29M
Industries
Advanced Materials,Biotechnology,Health Care,Life Science,Medical Device
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
VenoStent, Inc.

VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$6.18M
VenoStent has raised a total of $6.18M in funding over 2 rounds. Their latest funding was raised on Feb 23, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 23, 2021 Seed $3M 8 Creative Ventures — Detail
Aug 25, 2020 Seed $150K 1 Y Combinator — Detail
Jul 10, 2020 Grant $500K 1 — — Detail
Apr 26, 2020 Seed $535K 2 — — Detail
Oct 2, 2019 Non-Equity Assistant — 1 MassChallenge — Detail

Investors

Number of Lead Investors
Number of Investors
5
12
VenoStent is funded by 12 investors. Creative Ventures and Y Combinator are the most recent investors.
Investor Name Lead Investor Funding Round
Creative Ventures Yes Seed
Y Combinator Yes Seed
MassChallenge Yes Non-Equity Assistant
National Science Foundation Yes Grant
C3 Ventures — Seed
Cowtown Angels — Seed
IAG Capital Partners — Seed
Kube VC — Seed
Olima Ventures — Seed
SP Investment Fund — Seed

Employee Profiles

Number of Employee Profiles
2
VenoStent has 2 current employee profiles, including Executive Geoffrey Lucks
Executive
Executive